| Application no. and date | 18201062.9 (espacenet) (Federated) (European Patent Register), 20091221 | | Patent/reg. no. and date | DK/EP 3453387, 20200603 | | Publication date | 20190313 | | Priority no. and date | US 139672 P, 20081222, US 218530 P, 20090619, US 246715 P, 20090929 | | EP pub. no. and date |
EP 3453387 20190313 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | V2007-057-DK | | Inventor | Dumortier, Thomas, Novartis Pharma AG Postfach
4002 Basel, CH,
David, Olivier, Novartis Pharma AG Postfach
4002 Basel, CH,
Looby, Michael, Novartis Pharma AG Postfach
4002 Basel, CH,
SCHMOUDER, Robert, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/135 (2006.01) , A61K 31/137 (2006.01) , A61K 31/138 (2006.01) , A61K 31/661 (2006.01) , A61P 37/00 (2006.01) , A61P 37/06 (2006.01) | | Title | DOSERINGSPLAN TIL EN S1P-RECEPTORAGONIST | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
